Urinary biomarkers: Alone are they enough?

Journal of the American Society of Nephrology

Volumn 26, Issue 7, 2015, Pages 1485-1488

  Molitoris, Bruce A ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; SOMATOMEDIN BINDING PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ACUTE KIDNEY FAILURE; BIOCHEMICAL ANALYSIS; EARLY DIAGNOSIS; HUMAN; KIDNEY ISCHEMIA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; URINE LEVEL; ACUTE KIDNEY INJURY; FEMALE; HEMODIALYSIS; MALE; MORTALITY; PROCEDURES; URINE;

ACUTE KIDNEY INJURY; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MALE; RENAL DIALYSIS; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 84934760525     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014111145     Document Type: Review

References (17)

1. Bonventre JV, Vaidya VS, Schmouder R, Feig P, Dieterle F: Nextgeneration biomarkers for detecting kidney toxicity.Nat Biotechnol 28: 436-440, 2010
2. Molitoris BA, Melnikov VY, Okusa MD, Himmelfarb J: Technology insight: Biomarker development in acute kidney injury-what can we anticipate? Nat Clin Pract Nephrol 4: 154-165, 2008
3. Koyner JL, Vaidya VS, Bennett MR, Ma Q, Worcester E, Akhter SA, Raman J, Jeevanandam V, O'Connor MF, Devarajan P, Bonventre JV, Murray PT: Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol 5: 2154-2165, 2010
4. Murray PT,Mehta RL, Shaw A, Ronco C, Endre Z, KellumJA, Chawla LS, Cruz D, Ince C, Okusa MD; ADQI 10 workgroup: Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative Consensus conference. Kidney Int 85: 513-521, 2014
5. Parikh CR, Coca SG, Thiessen-Philbrook H, Shlipak MG, Koyner JL, Wang Z, Edelstein CL, Devarajan P, Patel UD, Zappitelli M, Krawczeski CD, Passik CS, Swaminathan M, Garg AX; TRIBE-AKI Consortium: Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J AmSoc Nephrol 22: 1748-1757, 2011
6. Coca SG, Garg AX, Thiessen-Philbrook H, Koyner JL, Patel UD, Krumholz HM, Shlipak MG, Parikh CR; TRIBE-AKI Consortium: Urinary biomarkers of AKI and mortality 3 years after cardiac surgery. J AmSoc Nephrol 25: 1063-1071, 2014
7. Koyner JL, Shaw AD, Lakhmir SC, Hoste, EAJ, Bihorac A, Kashani K, Haase M, Shi J, Kellum JA: TIMP2∗IGFBP7 levels are associated with adverse long-term outcomes in patients with AKI. J Am Soc Nephrol 26: 1747-1754, 2015
8. Schrier RW: Diagnostic value of urinary sodium, chloride, urea, and flow. J AmSoc Nephrol 22: 1610-1613, 2011
9. Perazella MA, Coca SG, Hall IE, Iyanam U, Koraishy M, Parikh CR: Urine microscopy is associated with severity and worsening of acute kidney injury in hospitalized patients. Clin J Am Soc Nephrol 5: 402-408, 2010
10. Haase M, Kellum JA, Ronco C: Subclinical AKI-an emerging syndrome with important consequences. Nat Rev Nephrol 8: 735-739, 2012
11. Siew ED,Ware LB, Ikizler TA: Biological markers of acute kidney injury. J Am Soc Nephrol 22: 810-820, 2011
12. Waikar SS, Betensky RA, Emerson SC, Bonventre JV: Imperfect gold standards for kidney injury biomarker evaluation. JAmSocNephrol 23: 13-21, 2012
13. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW: Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16: 3365-3370, 2005
14. Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann LM, Druml W, Bauer P, Hiesmayr M: Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: A prospective cohort study. J Am Soc Nephrol 15: 1597-1605, 2004
15. Stevens LA, Coresh J, Greene T, Levey AS: Assessing kidney function-measured and estimated glomerular filtration rate. N Engl JMed 354: 2473-2483, 2006
16. Udy AA, Baptista JP, Lim NL, Joynt GM, Jarrett P, Wockner L, Boots RJ, Lipman J: Augmented renal clearance in the ICU: Results of a multicenter observational study of renal function in critically ill patients with normal plasma creatinine concentrations. Crit Care Med 42: 520-527, 2014
17. Loupy A, Lefaucheur C, Vernerey D, Chang J, Hidalgo LG, Beuscart T, Verine J, Aubert O, Dubleumortier S, Duong van Huyen JP, Jouven X, Glotz D, Legendre C, Halloran PF: Molecular microscope strategy to improve risk stratification in early antibody-mediated kidney allograft rejection. J Am Soc Nephrol 25: 2267-2277, 2014